These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20213712)

  • 1. Statistical models for heart rate correction of the QT interval.
    Ring A
    Stat Med; 2010 Mar; 29(7-8):786-96. PubMed ID: 20213712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between study-specific and subject-specific heart rate corrections of the QT interval in investigations of drug induced QTc prolongation.
    Malik M; Hnatkova K; Batchvarov V
    Pacing Clin Electrophysiol; 2004 Jun; 27(6 Pt 1):791-800. PubMed ID: 15189536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QT analysis: a complex answer to a 'simple' problem.
    Li L; Desai M; Desta Z; Flockhart D
    Stat Med; 2004 Sep; 23(17):2625-43. PubMed ID: 15316947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
    Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
    Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnitude of error introduced by application of heart rate correction formulas to the canine QT interval.
    King A; Bailie M; Olivier NB
    Ann Noninvasive Electrocardiol; 2006 Oct; 11(4):289-98. PubMed ID: 17040276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure-response modeling approach for assessing QT effect in "thorough" QT/QTc studies.
    Hosmane B; Locke C; Chiu YL
    J Biopharm Stat; 2010 May; 20(3):615-31. PubMed ID: 20358440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bias and variance evaluation of QT interval correction methods.
    Wang Y; Pan G; Balch A
    J Biopharm Stat; 2008; 18(3):427-50. PubMed ID: 18470754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of subject-specific QT/RR curvatures in the design of individual heart rate corrections of the QT interval.
    Malik M; Hnatkova K; Kowalski D; Keirns JJ; van Gelderen EM
    J Electrocardiol; 2012; 45(6):571-81. PubMed ID: 22999325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statistical characterization of QT prolongation.
    Schall R; Ring A
    J Biopharm Stat; 2010 May; 20(3):543-62. PubMed ID: 20358435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian measurement error approach to QT interval correction and prolongation.
    Chen J; Zhao X
    J Biopharm Stat; 2010 May; 20(3):523-42. PubMed ID: 20358434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistical analysis methods for QT/QTc prolongation.
    Ma H; Smith B; Dmitrienko A
    J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A maximum likelihood approach for estimating the QT correction factor using mixed effects model.
    Shah A; Hajian G
    Stat Med; 2003 Jun; 22(11):1901-9. PubMed ID: 12754723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting time- and rate-based approaches for the assessment of drug-induced QT changes.
    Extramiana F; Badilini F; Sarapa N; Leenhardt A; Maison-Blanche P
    J Clin Pharmacol; 2007 Sep; 47(9):1129-37. PubMed ID: 17656619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subject-specific heart rate dependency of electrocardiographic QT, PQ, and QRS intervals.
    Malik M; Hnatkova K; Sisakova M; Schmidt G
    J Electrocardiol; 2008; 41(6):491-7. PubMed ID: 18817925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Air pollution effects on ventricular repolarization.
    Lux RL; Pope CA
    Res Rep Health Eff Inst; 2009 May; (141):3-20; discussion 21-8. PubMed ID: 19579527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonparametric approach to QT interval correction for heart rate.
    Wang D; Cheung YB; Arezina R; Taubel J; Camm AJ
    J Biopharm Stat; 2010 May; 20(3):508-22. PubMed ID: 20358433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sample size and power estimation in "thorough" QT/QTc studies with parallel group design.
    Hosmane B; Locke C; Chiu YL
    J Biopharm Stat; 2010 May; 20(3):578-86. PubMed ID: 20358437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of several methods for analyzing data from thorough QT studies.
    Tian H; Qiao W; Natarajan J
    J Biopharm Stat; 2010 May; 20(3):632-40. PubMed ID: 20358441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six commonly used QT correction models and their parameter estimation methods.
    Wang D; Taubel J; Arezina R
    J Biopharm Stat; 2012; 22(6):1148-61. PubMed ID: 23075014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of Individual QT/RR Profiles-Part 1: Inaccuracies and Problems of Population-Specific QT/Heart Rate Corrections.
    Malik M; Garnett C; Hnatkova K; Vicente J; Johannesen L; Stockbridge N
    Drug Saf; 2019 Mar; 42(3):401-414. PubMed ID: 30255349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.